The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer.
Alba Orea-SoufiSonia Castillo-LluvaNélida Salvador-TormoPaola Martín-CabreraSilvia RecueroEstíbaliz GabicagogeascoaManuel Moreno-ValladaresMarina Mendiburu-EliçabeAdrian Blanco-GomezJose M Ramos PittolElena García-TaboadaAlberto OcañaFrancisco J CimasAnder MatheuIsabel Álvarez-LópezGuillermo VelascoMar LorentePublished in: Cancers (2021)
Our findings support the exploration of TRIB3 as a potential biomarker and therapeutic target in luminal breast cancer.
Keyphrases